China Sanjiang Fine Chemicals Company Limited (2198.HK)
Jiaxing, CN
China Sanjiang Fine Chemicals Company Limited functions as an investment holding enterprise within the People's Republic of China, focusing on the production and distribution of a diverse range of chemical products. Its primary offerings include ethylene oxide, a vital intermediate for creating ethylene derivatives such as ethanolamines, glycol ethers, and various surfactants. The company also supplies ethylene glycol, used in the synthesis of bio-organic compounds like mono ethylene glycol. Propylene is another key product, essential for manufacturing polypropylene, acrylonitrile, propylene oxide, and acetone. Additionally, it produces polypropylene, a versatile thermoplastic resin applied in knitting, injection molding, films, fibers, and pipe manufacturing. Methyl tert-butyl ether (MTBE) is provided as a gasoline additive to enhance octane ratings and serve as a fuel component. The company also offers surfactants, which are integral across various sectors as scouring, moisturizing, emulsifying, and solubilizing agents. Beyond these core chemicals, Sanjiang Fine Chemicals manufactures and supplies carbon four, crude pentene, and industrial gases including oxygen, nitrogen, and argon. Its service portfolio includes processing for polypropylene, MTBE, and surfactants, along with leasing and storage solutions. The company also provides asset and supply chain management services. Further expanding its operations, China Sanjiang Fine Chemicals is involved in the construction and ongoing management of a pipe network within the Jiaxing Port Chemical Industrial Park. It also engages in the manufacturing and sale of fertilizers, plastics, alcohol ethoxylate, nonylphenols, textile auxiliaries, and polyethylene, complemented by equipment rental services. Established in 2009, the company's headquarters are located in Jiaxing, People's Republic of China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.15% | -21.40% | -35.00% | -30.88% | +25.65% | +9.74% | +93.14% | +126.85% | +5.96% | +196.49% | +1.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-5.7% Q4'25: +9.7% (vs Q4'23)
-
EPS growth Chemicals: +11.7%-23.9% Q4'25: +62.5% (vs Q4'23)
-
FCF margin FCF growth · Chemicals: +41.7%-4.9% Q4'25: -16.2% (vs Q4'23)
-
EBIT margin Chemicals: +7.1%+3.3% Q4'25: +3.8% (vs Q4'23)
-
ROIC Chemicals: +3.4%+3.2% Q4'25: +5.7% (vs Q4'23)
-
Share dilution Chemicals: +0.0%-0.1% ★ Q4'25: -0.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×7.24× Q4'25: 3.14× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2010 actual |
Dec 2011 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.58B
est: 1.75B (-9.4%)
|
2.08B
est: 2.13B (-2.3%)
|
3.94B
est: 4.72B (-16.5%)
|
3.64B
est: 3.69B (-1.5%)
|
4.97B
est: 7.00B (-29.1%)
|
6.65B
est: 8.62B (-22.9%)
|
8.90B
est: 8.36B (+6.5%)
|
9.59B
est: 10.07B (-4.8%)
|
9.19B
est: 9.03B (+1.8%)
|
8.32B
est: 9.52B (-12.6%)
|
9.50B
est: 9.26B (+2.6%)
|
8.82B
est: 14.76B (-40.2%)
|
13.13B
est: 10.89B (+20.6%)
|
19.59B
est: 11.29B (+73.4%)
|
| EBITDA |
409.78M
est: 142.66M (+187.3%)
|
588.41M
est: 475.48M (+23.8%)
|
220.65M
est: 1.06B (-79.1%)
|
-147.72M
est: 651.46M (-122.7%)
|
-169.08M
est: 571.80M (-129.6%)
|
913.27M
est: 703.95M (+29.7%)
|
565.65M
est: 873.59M (-35.3%)
|
359.42M
est: 1.52B (-76.3%)
|
1.31B
est: 737.60M (+77.3%)
|
1.64B
est: 777.36M (+110.7%)
|
388.69M
est: 1.13B (-65.6%)
|
349.18M
est: 1.17B (-70.2%)
|
812.91M
est: 1.22B (-33.1%)
|
1.35B
est: 680.99M (+98.8%)
|
| EBIT |
337.66M
est: 53.97M (+525.6%)
|
496.33M
est: 387.93M (+27.9%)
|
54.87M
est: 861.22M (-93.6%)
|
-317.54M
est: 550.61M (-157.7%)
|
112.01M
est: 216.34M (-48.2%)
|
298.69M
est: 266.34M (+12.1%)
|
16.42M
est: 661.55M (-97.5%)
|
-181.41M
est: 1.14B (-115.9%)
|
709.35M
est: 279.07M (+154.2%)
|
1.07B
est: 294.11M (+263.9%)
|
-104.88M
est: 951.17M (-111.0%)
|
-196.17M
est: 987.78M (-119.9%)
|
235.11M
est: 1.02B (-77.1%)
|
808.18M
est: 132.72M (+508.9%)
|
| Net Income |
266.13M
est: 252.49M (+5.4%)
|
404.77M
est: 324.00M (+24.9%)
|
605.13M
est: 719.30M (-15.9%)
|
132.78M
est: 473.06M (-71.9%)
|
-145.50M
est: -69.36M (-109.8%)
|
552.61M
est: 540.01M (+2.3%)
|
690.79M
est: 434.15M (+59.1%)
|
398.92M
est: 871.70M (-54.2%)
|
550.47M
est: 319.43M (+72.3%)
|
1.12B
est: 1.08B (+4.0%)
|
380.61M
est: 605.34M (-37.1%)
|
-307.88M
est: 628.64M (-149.0%)
|
91.48M
est: 652.06M (-86.0%)
|
532.55M
est: 813.50M (-34.5%)
|
| SGA |
65.57M
est: 45.53M (+44.0%)
|
77.44M
est: 79.87M (-3.1%)
|
153.65M
est: 177.33M (-13.4%)
|
134.12M
est: 120.32M (+11.5%)
|
208.59M
est: 182.49M (+14.3%)
|
344.38M
est: 224.67M (+53.3%)
|
285.80M
est: 270.56M (+5.6%)
|
352.46M
est: 372.53M (-5.4%)
|
313.38M
est: 235.40M (+33.1%)
|
419.52M
est: 248.09M (+69.1%)
|
282.19M
est: 321.06M (-12.1%)
|
201.31M
est: 333.42M (-39.6%)
|
201.46M
est: 345.84M (-41.7%)
|
235.61M
est: 214.99M (+9.6%)
|
| EPS |
0.35
est: 0.22 (+60.5%)
|
0.40
est: 0.30 (+33.2%)
|
0.61
est: 0.49 (+25.6%)
|
0.13
est: 0.11 (+20.7%)
|
-0.15
est: -0.06 (-150.4%)
|
0.56
est: 0.47 (+20.1%)
|
0.67
est: 0.51 (+31.4%)
|
0.39
est: 0.32 (+20.2%)
|
0.46
est: 0.28 (+66.7%)
|
0.95
est: 0.93 (+1.9%)
|
0.32
est: 1.01 (-68.4%)
|
-0.26
est: 1.62 (-116.0%)
|
0.08
est: 1.95 (-96.0%)
|
0.46
est: 0.70 (-34.2%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-28 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-27 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-14 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.02% | 18.7K | 0.42% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 101.4K | 0.65% |
| 3 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.01% | 23.9K | 0.33% |
| 4 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 15.1K | 0.35% |
| 5 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 420.3K | 0.39% |
| 6 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 87.6K | 0.46% |
| 7 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 195.1K | 0.29% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 204.3K | 0.28% |
| 9 | Avantis Emerging Markets Value ETF AVES | 0.00% | 10.2K | 0.36% |
| 10 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 107.2K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Huotao Rao | Executive Director | 1M | male |
| Siyi Guan | Executive Director | 1M | female |
| Xian Chen | Executive Director | 1M | female |
| Jianhong Han | Founder & Chairlady of the Board | 248.4K | female |
| Ngai Hang Yip FCPA FCCA | Company Secretary & Financial Controller | — | male |
| Rong Guo Ding | Head of Production Department | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2198.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
